SerbinCreative

(805) 963-0439 | Toll-Free (800) 876-6425

www.serbincreative.com LA / NY / UK

AtEdge

AtEdge

Photography & Motion

Directory of Illustration

Directory of Illustration

Find the world's best illustrators

PLAY! Illustration

PLAY!

Illustration for Toys & Interactive Games

Lattis Social

Social Media for the Creative Industry

More from Serbin

JavaScript may be disabled in your browser. Please enable JavaScript for access to all site features.

Home
>
Artists
>
Kryski Biomedia

Kryski Biomedia

Your risk of heart disease: overview

CNP Mechanism of Action

medical illustration of This editorial illustration in the Boston Heart personalized patient Diagnostic Report was the backdrop for a Results Overview 2-page spread. The overview provided the patient with a snap-shot view of their own heart disease risk and how each of four main factors (lipids, inflammation, metabolics, and genetics) is contributing to their risk.

medical illustration of This is an illustration of Revcovi, a new enzyme replacement therapy (ERT) for the treatment of patients with adenosine deaminase severe combined immune deficiency (ADA-SCID). The enzyme uses recombinant technology. A succinimidyl carbamate (SC) linker links to PEG to the rADA protein. Client: Leadiant Biosciences

PEGylated rADA enzyme

This editorial illustration in the Boston Heart personalized patient Diagnostic Report was the backdrop for a Results Overview 2-page spread. The overview provided the patient with a snap-shot view of their own heart disease risk and how each of four main factors (lipids, inflammation, metabolics, and genetics) is contributing to their risk.

Keywords: Color, Design, Information Graphics, Advertising / Marketing, Patient Education, Anatomy, Cardiac Surgery / Cardiology, Disease Management, General Medicine, Pathology

© 2015 Kryski Biomedia